Category: Business

Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial Evaluating Topical Ocular Delivery of ST266 For the Treatment of Persistent Corneal Epithelial Defects

PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announc…

Global $673.2Mn Optical Lens Edgers Market Outlook Report, 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Optical Lens Edgers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026” report has been added to ResearchAndMarkets.com’s offering. The global optical lens edgers market was valued at US$ 380.5 million in 2017 and is expected to reach US$ 673.2 million by 2026, expanding at a CAGR of 6.7% from 2018 to 2026. Key Market Movements Growing senescent population and increas

Global Vision Care Market 2019-2023 – Shift to E-commerce Platforms & Growing Preference for Daily Disposable Contact Lenses – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca

International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos’ iStent inject® in Glaucoma Patients with Substantial Disease Burden

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…

Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025” report has been added to ResearchAndMarkets.com’s offering. Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increas